<code id='3BCB9B72EB'></code><style id='3BCB9B72EB'></style>
    • <acronym id='3BCB9B72EB'></acronym>
      <center id='3BCB9B72EB'><center id='3BCB9B72EB'><tfoot id='3BCB9B72EB'></tfoot></center><abbr id='3BCB9B72EB'><dir id='3BCB9B72EB'><tfoot id='3BCB9B72EB'></tfoot><noframes id='3BCB9B72EB'>

    • <optgroup id='3BCB9B72EB'><strike id='3BCB9B72EB'><sup id='3BCB9B72EB'></sup></strike><code id='3BCB9B72EB'></code></optgroup>
        1. <b id='3BCB9B72EB'><label id='3BCB9B72EB'><select id='3BCB9B72EB'><dt id='3BCB9B72EB'><span id='3BCB9B72EB'></span></dt></select></label></b><u id='3BCB9B72EB'></u>
          <i id='3BCB9B72EB'><strike id='3BCB9B72EB'><tt id='3BCB9B72EB'><pre id='3BCB9B72EB'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:37
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more
          GSK’s asthma push continues as drug succeeds in Phase 3 trials
          GSK’s asthma push continues as drug succeeds in Phase 3 trials

          AkiraSuemori/APAnewasthmatreatmentthatcouldbeadministeredjustonceeverysixmonthshassucceededintwoPhas

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Warren pushes Witty on UnitedHealth's control over physicians

          KentNishimura/GettyImagesYou’rereadingthewebversionofHealthCareInc.,STAT’sweeklynewsletterfollowingt